Altfest L J & Co. Inc. Purchases 3,715 Shares of Johnson & Johnson $JNJ

Altfest L J & Co. Inc. lifted its holdings in Johnson & Johnson (NYSE:JNJ) by 27.5% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 17,244 shares of the company’s stock after purchasing an additional 3,715 shares during the period. Altfest L J & Co. Inc.’s holdings in Johnson & Johnson were worth $3,197,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. SOA Wealth Advisors LLC. increased its stake in shares of Johnson & Johnson by 0.7% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 7,392 shares of the company’s stock worth $1,371,000 after purchasing an additional 53 shares in the last quarter. Heritage Oak Wealth Advisors LLC lifted its position in Johnson & Johnson by 3.5% during the third quarter. Heritage Oak Wealth Advisors LLC now owns 1,639 shares of the company’s stock valued at $304,000 after purchasing an additional 55 shares in the last quarter. Lifestyle Asset Management Inc. increased its position in Johnson & Johnson by 3.4% in the third quarter. Lifestyle Asset Management Inc. now owns 1,683 shares of the company’s stock worth $312,000 after buying an additional 56 shares in the last quarter. Wynn Capital LLC raised its stake in shares of Johnson & Johnson by 0.4% in the third quarter. Wynn Capital LLC now owns 15,930 shares of the company’s stock worth $2,954,000 after buying an additional 57 shares during the period. Finally, Defined Financial Planning LLC lifted its position in shares of Johnson & Johnson by 3.0% during the 3rd quarter. Defined Financial Planning LLC now owns 1,926 shares of the company’s stock valued at $365,000 after buying an additional 57 shares in the last quarter. 69.55% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on JNJ shares. Morgan Stanley increased their target price on shares of Johnson & Johnson from $190.00 to $197.00 and gave the stock an “equal weight” rating in a report on Friday, December 12th. Scotiabank started coverage on shares of Johnson & Johnson in a research note on Thursday, November 13th. They set a “sector outperform” rating and a $230.00 target price on the stock. UBS Group reaffirmed a “buy” rating on shares of Johnson & Johnson in a report on Monday. Citigroup raised their price target on Johnson & Johnson from $215.00 to $232.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Finally, JPMorgan Chase & Co. boosted their price objective on Johnson & Johnson from $185.00 to $200.00 and gave the company a “neutral” rating in a research report on Tuesday, September 16th. Four investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $212.62.

Johnson & Johnson Stock Down 1.5%

Shares of JNJ stock opened at $204.32 on Tuesday. The company’s fifty day simple moving average is $201.45 and its two-hundred day simple moving average is $183.45. Johnson & Johnson has a 52 week low of $140.68 and a 52 week high of $215.18. The stock has a market cap of $492.26 billion, a P/E ratio of 19.72, a PEG ratio of 2.13 and a beta of 0.34. The company has a quick ratio of 0.80, a current ratio of 1.07 and a debt-to-equity ratio of 0.50.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The firm had revenue of $24.02 billion during the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. Analysts predict that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, February 24th. This represents a $5.20 dividend on an annualized basis and a yield of 2.5%. Johnson & Johnson’s payout ratio is presently 50.19%.

About Johnson & Johnson

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.